- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Bullion Gold Resources Corp (2): Bullion Gold Resources private placement | 1 | Stockwatch | ||
| Do | Bullion Gold Resources Corp (2): Bullion Gold private placement | 1 | Stockwatch | ||
| Di | Bullion Gold Resources Corporation: Bullion Gold Begins Exploration Work on Bodo | 604 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 3, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the imminent launch of a second exploration program... ► Artikel lesen | |
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 09.05. | Bullion Gold Resources Corp (2): Bullion Gold signs LOI for Cadillac Extension project | 1 | Stockwatch | ||
| 08.05. | Bullion Gold Resources Corporation: Bullion Gold Acquires the Cadillac Extension (Langlade) Project | 198 | Newsfile | Montreal, Quebec--(Newsfile Corp. - May 8, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the signing of a letter of intent to acquire 100%... ► Artikel lesen | |
| 04.04. | Bullion Gold Resources Corp (2): Bullion receives TSX-V approval for Bousquet option | 1 | Stockwatch | ||
| 04.04. | Bullion Gold Resources Corporation: Bullion Gold Completes Transaction on Bousquet Property with Olympio Metals and Closes Financing | 1.636 | Newsfile | Montreal, Quebec--(Newsfile Corp. - April 4, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces that the option agreement on the Bousquet property with Olympio... ► Artikel lesen | |
| 28.03. | Bullion Gold Resources Corp (2): Bullion Gold sale of option for Bousquet | 1 | Stockwatch | ||
| 18.03. | Bullion Gold Resources Corp (2): Bullion Gold signs option agreement with Olympio | 1 | Stockwatch | ||
| 18.03. | Bullion Gold Resources Corporation: Bullion Gold Signs Option Agreement with Olympio Metals for the Bousquet Project | 471 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 18, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the signing of an option agreement with Olympio Metals ("Olympio"... ► Artikel lesen | |
| 25.02. | Bullion Gold Resources Corp (2): Bullion Gold grants option to sell 80 per cent of Bousquet | 1 | Stockwatch | ||
| 25.02. | Bullion Gold Resources Corporation: Bullion Gold Grants Option on Its Bousquet Project to Olympio Metals | 530 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 24, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the signing of a letter of intent with Olympio Metals (ASX:... ► Artikel lesen | |
| 14.01. | Bullion Gold Resources Corp (2): Bullion Gold appoints Morissette as president, CEO | 1 | Stockwatch | ||
| 14.01. | Bullion Gold Resources Corporation: Morissette Joins Bullion Gold to Develop the Bodo Project | 722 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 14, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the appointment of Mr. Guy Morissette as President and Chief... ► Artikel lesen | |
| 03.01. | Bullion Gold Resources Corp (2): Bullion Gold closes $448,450 private placement | 1 | Stockwatch | ||
| 03.01. | Bullion Gold Resources Corporation: Bullion Gold Completes Private Placement | 3.397 | Newsfile | Montréal, Québec--(Newsfile Corp. - January 3, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has closed a private placement (the "Offering")... ► Artikel lesen | |
| 04.12.24 | Bullion Gold Resources Corporation: Moore and Gervais Appointed Directors of Bullion Gold Resources | 897 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 4, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the appointments of MM. Jean-David Moore and... ► Artikel lesen | |
| 13.11.24 | Bullion Gold Resources Corporation: Bullion Prepares $1M Financing and Presents Summary of Its Gold and Polymetallic Projects | 514 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 13, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") will undertake a non-brokered private placement for minimum aggregate... ► Artikel lesen | |
| 27.08.24 | Bullion Gold Resources Corporation: Bullion Gold Bodo Project: Samples Reveal Significant Gold, Silver and Copper Grades | 893 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 27, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") announces new sampling results from its Bodo project. Despite the short... ► Artikel lesen | |
| 18.06.24 | Bullion Gold Resources Corporation: Bullion Gold Discovers New Massive Sulphide Zone on Bodo Property, James Bay, Quebec | 353 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 18, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") announces that it has completed the first phase of its 2024 exploration... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PHATHOM PHARMACEUTICALS | 8,920 | +90,19 % | Phathom Pharmaceuticals, Inc. - 8-K, Current Report | ||
| AVIDITY BIOSCIENCES | 36,240 | +1,83 % | Avidity Biosciences, Inc.: Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SAN DIEGO, May 21, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics... ► Artikel lesen | |
| QIAGEN | 40,060 | -0,55 % | DEUTSCHE BANK RESEARCH stuft QIAGEN NV auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Qiagen von 47 auf 50 US-Dollar angehoben und die Einstufung auf "Buy" belassen. Analyst Jan Koch zog in seinem am Dienstag... ► Artikel lesen | |
| ARCELLX | 68,10 | +2,81 % | Arcellx, Inc.: Arcellx Announces Its Participation at TD Cowen's 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025 | Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 14,370 | +6,37 % | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| RECURSION PHARMACEUTICALS | 5,485 | +20,02 % | Recursion Pharmaceuticals shares surge on AI model release | ||
| TARSUS PHARMACEUTICALS | 43,920 | -0,39 % | Oppenheimer assumes Tarsus stock at outperform on strong sales | ||
| BIONTECH | 95,35 | +0,05 % | BioNTech SE: BioNTech und Bristol Myers Squibb geben globale strategische Partnerschaft zur gemeinsamen Entwicklung und Kommerzialisierung des bispezifischen Antikörperkandidaten BNT327 in einer Vielzahl solider Tumorarten bekannt | BioNTechs bispezifischer PD-L1xVEGF-Antikörper BNT327 ist ein Immuntherapiekandidat in der fortgeschrittenen klinischen Entwicklung, der das Potenzial hat für verschiedene Tumorarten einen neuen Behandlungsstandard... ► Artikel lesen | |
| VERA THERAPEUTICS | 22,760 | -25,69 % | Vera Therapeutics Announces Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial in Adults with IgA Nephropathy | Atacicept ORIGIN Phase 3 trial met the primary endpoint of reduction in proteinuria (UPCR) at week 36; participants receiving atacicept achieved a 46% reduction from baseline and 42% reduction compared... ► Artikel lesen | |
| MOONLAKE IMMUNOTHERAPEUTICS | 46,880 | -3,99 % | ROUNDUP/Aktien New York: Knappes Plus - Gelassenheit trotz Zoll-Unruhen | NEW YORK (dpa-AFX) - Die US-Börsen haben am Dienstag knappe Kursgewinne erzielt. Die jüngst wieder aufflackernden, internationalen Handelsstreitigkeiten wegen der amerikanischen Zollpolitik scheinen... ► Artikel lesen | |
| EDGEWISE THERAPEUTICS | 15,240 | +2,83 % | RBC Capital behält Outperform-Rating für Edgewise Therapeutics-Aktie bei | ||
| JANUX THERAPEUTICS | 26,210 | +5,86 % | Leerink cuts Janux Therapeutics price target to $89, keeps Outperform | ||
| EVOTEC | 7,060 | +0,94 % | Evotec Aktie: Ohne Übernahme sieht es schlecht aus! Auf diese Kursmarke kommt es an! | © Foto: Finanznachrichten (Symbolbild)Zwischen Kursrakete mit Übernahmefantasie und Korrekturmodus Richtung Süden. Der Biotech-Titel aus Hamburg liefert seit Wochen ein Wechselbad der Gefühle. Kann... ► Artikel lesen | |
| 89BIO | 10,250 | +3,12 % | 89bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| TREVI THERAPEUTICS | 7,060 | +4,75 % | Trevi Therapeutics, Inc.: Trevi Therapeutics Announces Positive Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough | Haduvio met the primary endpoint with statistically-significant reductions in 24-hour cough frequency across all dose groups (108 and 54 mg BID p
Patients saw a... ► Artikel lesen |
Das Unternehmen BULLION GOLD RESOURCES CORPORATION kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.